Skip to content
HowShorted

Ginkgo Bioworks Holdings, Inc. short interest in 2025

In 2025, Ginkgo Bioworks Holdings, Inc.'s disclosed short interest ran from 13.62% of shares outstanding on 15 Jan 2025 to 11.01% on 31 Dec 2025, a change of -2.61 percentage points. The year's high was 22.99% on 15 Apr 2025 and its low 9.87% on 30 Sep 2025, averaging 15.04% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.70 days on 30 May 2025. Full history: Ginkgo Bioworks Holdings, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Ginkgo Bioworks Holdings, Inc. in 2025

2025 in figures

Start of year
13.62% (15 Jan 2025)
End of year
11.01% (31 Dec 2025)
Change
-2.61 pp
High
22.99% (15 Apr 2025)
Low
9.87% (30 Sep 2025)
Average
15.04%
Highest days to cover
11.70 (30 May 2025)
SEC filings marked
8

Every report in 2025

Ginkgo Bioworks Holdings, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202513.62%5.50
31 Jan 202514.36%6.19
14 Feb 202515.23%4.19
28 Feb 202515.62%3.5410-K filed, results (8-K)
14 Mar 202517.19%6.53
31 Mar 202519.64%9.69
15 Apr 202522.99%7.28
30 Apr 202519.87%10.95
15 May 202519.64%10.1410-Q filed, results (8-K)
30 May 202520.19%11.70
13 Jun 202519.33%9.83
30 Jun 202520.54%6.66
15 Jul 202517.67%7.42
31 Jul 202513.94%4.28
15 Aug 202512.00%4.4110-Q filed, results (8-K)
29 Aug 202511.33%4.15
15 Sep 202510.60%3.77
30 Sep 20259.87%3.74
15 Oct 202511.24%3.37
31 Oct 202511.83%5.91
14 Nov 202511.62%4.7710-Q filed, results (8-K)
28 Nov 202510.94%6.62
15 Dec 202510.72%6.57
31 Dec 202511.01%6.63

See also: Ginkgo Bioworks Holdings, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.